vusolimogene,nivolumab,rp1
bms,replimune
['ignyte', 'nivolumab', 'rp1', 'nivo', '$repl']
according to asco, the $repl poster on
"updated results from the skin cancer cohorts from an ongoing phase 1/2 multi-cohort study of rp1, an enhanced potency oncolytic hsv, combined with nivolumab (ignyte)" should be out by 2:15pm et. no pr or poster on 
biotech freestyler

ist „pride“ ähnlich sinnfrei wie „nationalstolz“?

„Mündigkeit ist vor allem Einsamkeitsfähigkeit“

Kämpft per Rennvelo gen SUV Windmühlen